Nanopath
Brief
Nanopath is a women-led company dedicated to improving health equity worldwide, starting with women's health.
Profile
Nanopath's proprietary molecular diagnostic testing platform takes a radically new approach to how clinicians characterize human health.
The company's novel biosensing technology has the potential to enable fast, high-complexity testing at the point-of-care, rather than in centralized laboratories.
The company is headquartered in Cambridge, Mass., at The Engine built by MIT, a premier facility for high-potential, tough-tech start-ups. Nanopath is backed by Norwest, the Medtech Convergence Fund, a SV Health Investors Fund, Gingerbread Capital and Alumni Ventures.
Headquarters
